Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Grace Therapeutics, Inc
GRCE
Healthcare
Biotechnology
Grace Therapeutics, Inc., formerly Acasti Pharma Inc., is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its therapeutic pipeline consists of three clinical-stage drug candidates supported by an intellectual property portfolio of over 40 granted and pending patents in various jurisdictions. Its lead drug candidate, GTX-104, is a clinical-stage, novel...
, injectable formulation of nimodipine being developed for intravenous (IV) infusion in aneurysmal subarachnoid hemorrhage (aSAH) patients to address significant unmet medical needs. GTX-104 provides a convenient IV delivery of nimodipine in the intensive care unit, eliminating the need for nasogastric tube administration in unconscious or dysphagic patients. Its other pipeline drug candidates include GTX-102, which is an oral-mucosal betamethasone spray for the treatment of Ataxia Telangiectasia and GTX-101, which is a topical bio adhesive film-forming bupivacaine spray for Postherpetic Neuralgia.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:GRCE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Next
(105)
•••
postie1
X
Post by
postie1
on Sep 21, 2020 7:22pm
Somebody likes that new CFO
The market seems to like the new person or is this just a run and dump move the last couple of days. Seems to have a proven track record. Maybe there are more resignations coming which would be
...more
(2)
•••
Weeble
X
Comment by
Weeble
on Sep 11, 2020 4:21pm
RE:Mgmt circ on sedar
I can't believe the options. This company is obscene and cares nothing about shareholders. I am seriously thinking of buying the stock again just so that I can help vote the board out.
(310)
•••
inspecthrgadget
X
Post by
inspecthrgadget
on Sep 11, 2020 1:50pm
Was this formerly Route1?
Tia
(3)
•••
boozehound3
X
Post by
boozehound3
on Sep 11, 2020 12:36pm
Oh no francine
Bollie is gone. No more inside info for you I actually feel bad for you. From about 800 000 to 40 000 and heading lower. Ouch
(2118)
•••
lscfa
X
Post by
lscfa
on Sep 09, 2020 10:07pm
Mgmt circ on sedar
Do these bozos expect to be re-elected as director? Roderick N. Carter California, United States Chairman of the Board Principal, Aquila Life Sciences LLC 2015
...more
(3)
•••
boozehound3
X
Post by
boozehound3
on Sep 09, 2020 3:53pm
ComeOn francine
Give us an update. What had Bollie had to say about this disaster
(77)
•••
Rosmorduc
X
Post by
Rosmorduc
on Sep 09, 2020 10:55am
I can't believe Jan is still there
What is the board waiting for to kick her ugly behind out?
(96)
•••
SunsetGrill
X
Post by
SunsetGrill
on Sep 04, 2020 5:40pm
So how will Pierre ever get his tooth?
I was really hoping this would be a blockbuster drug so Pierre could sell one share and purchase a tooth. Oh well maybe Francene can sit out in front of Tim Hortons with a tin cup and recieve
...more
(20)
•••
Swingzup1
X
Post by
Swingzup1
on Sep 04, 2020 4:29pm
Load up now for technical bounce then never again
Company is sitting extremely oversold. I was never a holder of this company but will be playing the technical bounce bought 20k at .28 I suggest u guys load for the bounce also to salvage some of your
...more
(77)
•••
Rosmorduc
X
Comment by
Rosmorduc
on Sep 04, 2020 3:09pm
RE:Incompetence
Yes indeed. Most of us learned it the hard way. I will never again invest in a company with poor management. All the signals were there with Jan that she was not only incompetent but also
...more
(4)
•••
19LDS84
X
Post by
19LDS84
on Sep 04, 2020 9:53am
Incompetence
You can't have success if the leaders are incompetent. It just doesn't work. Now you have to hope that the secondary points will reduce your losses. Fire Jan, sell the patents, find something
...more
(106)
•••
G1945V
X
Post by
G1945V
on Sep 03, 2020 4:10pm
Post-hoc analysis
What will that bring to bear. Will that save CaPre. G1945V
(96)
•••
SunsetGrill
X
Comment by
SunsetGrill
on Sep 03, 2020 9:13am
RE:Echelon says sell
LOL - a day late and a dollar short maybe Francine (and her connected friends) can take the company private
(2118)
•••
lscfa
X
Post by
lscfa
on Sep 03, 2020 12:57am
Echelon says sell
https://www.cantechletter.com/2020/09/sell-acasti-pharma-says-echelon-wealth/
(4)
•••
CanadianBacon83
X
Comment by
CanadianBacon83
on Sep 02, 2020 5:29pm
RE:brain dead idiots
you won what? how did you win by not owning any stock whos price fell? youre a sad lonely and pathetic little man lol
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Eminent's First Drill Hole Hits Significant Gold-Arsenic in Getchell Trend Analogue and Second Hole Drilling Commences
U.S. DOD Logistics Agency Highlights V.GPH Project to Develop Eco-Friendly Graphite-Based Fire-Fighting Material
Have you held units of a TD mutual fund, other than through a discount broker? Learn more.
Alphamin Announces Record Fy2024 & Q4 2024 Tin Production Fy2025 Production Guidance Exploration Success
BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a market projected to grow to USD$48,000,000,000 by 2030*